Royal Bank of Canada »

Eloxx Pharmaceuticals shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Eloxx Pharmaceuticals shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Eloxx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eloxx Pharmaceuticals held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eloxx Pharmaceuticals by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.0k 98 10.20

More positions owned by Royal Bank of Canada

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Rbc Cad (RY)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Toronto Dominion Bk Ont Com New (TD)
Amazon (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Bank Of Montreal Cadcom (BMO)
Alphabet Cap Stk Cl C (GOOG)
Cibc Cad (CM)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)

View all positions for Royal Bank of Canada

Top funds holding Eloxx Pharmaceuticals

Nantahala Capital Management
EcoR1 Capital
Standard Life Aberdeen
Samsara BioCapital
Siren
Stonepine Capital Management
Vanguard Capital Management
Vanguard Fiduciary Trust
Seven Grand Managers
Vanguard Global Advisers
UBS Group
Wells Fargo & Company
Royal Bank of Canada
Pioneer Family Office
Altshuler Shaham

View all funds holding Eloxx Pharmaceuticals